Search details
1.
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.
N Engl J Med
; 379(20): 1926-1936, 2018 Nov 15.
Article
in English
| MEDLINE | ID: mdl-30345905
2.
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
Breast Cancer Res Treat
; 184(1): 23-35, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32783178
3.
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.
N Engl J Med
; 373(3): 209-19, 2015 Jul 16.
Article
in English
| MEDLINE | ID: mdl-26030518
4.
Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Int J Technol Assess Health Care
; 28(1): 12-21, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22617734
5.
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
J Clin Oncol
; 37(14): 1169-1178, 2019 05 10.
Article
in English
| MEDLINE | ID: mdl-30807234
6.
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.
Eur J Cancer
; 104: 21-31, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30308388
7.
PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients.
J Glob Oncol
; 3(4): 289-303, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-28831437
8.
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer.
Mol Oncol
; 9(7): 1384-91, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25888067
9.
An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer.
Breast
; 21(6): 716-23, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23022045
10.
Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer.
Breast
; 21(4): 507-13, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22336056
11.
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
J Clin Oncol
; 30(9): 921-9, 2012 Mar 20.
Article
in English
| MEDLINE | ID: mdl-22331954
Results
1 -
11
de 11
1
Next >
>>